A systematic review to assess seizure risk with chloroquine therapy in persons with epilepsy
View ORCID ProfileSandipan Pati
doi: https://doi.org/10.1101/2020.04.09.20056358
Sandipan Pati
1Department of Neurology, University of Alabama at Birmingham, AL
2Epilepsy and Cognitive Neurophysiology Laboratory, University of Alabama at Birmingham, AL

Data Availability
this is no clinical data. This is a systematic review
Posted April 14, 2020.
A systematic review to assess seizure risk with chloroquine therapy in persons with epilepsy
Sandipan Pati
medRxiv 2020.04.09.20056358; doi: https://doi.org/10.1101/2020.04.09.20056358
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)